Protocols

Shire CFO to jump ship; Akari taps Zealand vet as new CEO

Jeff Poulton

⇨ Shire CFO Jeff Poulton is jumping ship in order to take the same position at Indigo, a startup in the plant microbiome world. He’s leaving at the end of the year, giving Shire plenty of time to recruit a new CFO to take his place.

⇨ More than two months after Akari Therapeutics’ CEO Gur Roshwalb abruptly left the company after some of its data had to be restated, the biotech has recruited David Horn Solomon, the former CEO of Zealand Pharma, for the post.

⇨ Shares of Hackensack, NJ-based Champions Oncology $CSBR jumped on the announcement that it has struck a deal to work with AstraZeneca on novel cohorts of PDX models for use in its R&D group.

⇨ IBM is putting its machine learning tech to use to examine the causes of Type 1 diabetes in children, part of a new initiative it struck with JDRF.


The best place to read Endpoints News? In your inbox.

Full-text daily reports for those who discover, develop, and market drugs. Join 21,000+ biopharma pros who read Endpoints News by email every day.

Free Subscription

Biomanufacturing